Log In
Print
BCIQ
Print
Print this Print this
 

Expanded autologous mixed cell therapy, ixmyelocel-T (formerly Cardiac Repair Cells (CRCs), Tissue repair cells, Vascular repair cells)

  Manage Alerts
Collapse Summary General Information
Company Aastrom Biosciences Inc.
DescriptionAutologous cell therapy made from bone marrow containing adult stem and progenitor cells using the Tissue Repair Cell technology
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today